The invention discloses a Chinese herbal medicine in the treatment of sequels of stroke and hemiplegia. The active pharmaceutical ingredient and weight ratios are demonstrated as follows: ground beetle 3-10g, astragalus 9-40g, codonopsis pilosula extract 10-30g, leonurus japonicus 9-30g, danshen root 9-15g, cyathula root 5-10g, peach kernel 5-10g, Jiang Chong 10-20g, safflower 5-9g, rhizoma ligustici wallichii 5-15g, scorpion 3-9g, lumbricus 5-10g, red peony root 6-12g, poria cocos 5-15g, chinese starjasmine stem 6-12g, stephania root 5-15g, coix seed 9-30g, crab apple 9-12g, eucommia bark 6-15g, combined spicebush root 5-10g, largehead atractylodes rhizome 6-15g, oriental waterplantain rhizome 6-15g, milettia reticulata 10-20g, gambir plant 5-12g, angelica sinensis 5-15g, turmeric rhizome 5-9g, cassia twig 3-9g, mulberry twig 10-20g, chinese clematis root 6-10g. That the sequels of stroke and hemiplegia are difficult to cure is because that muscle and joints are blocked by phlegm and blood stasis, which is caused by the deficiency of Qi. The prescription based on the pathogenesis, by righting and supporting the healthy energy, activating blood circulation to dissipate blood stasis, reducing phlegm and adjusting the balance of Yin and Yang, removes the causes of the illness and the total efficiency for the prescription is more than 98%.